Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-27

Clinical Trial Update: Furosemide Pharmacodynamics and Pharmacokinetics After Subcutaneous or Oral Administration [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update reporting pharmacodynamics and pharmacokinetics of furosemide after subcutaneous or oral administration in heart failure patients, spannin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FUROSEMIDE (Furosemide)

Snippet

Sponsor: scPharmaceuticals, Inc. | Conditions: Heart Failure | Phase 1, Phase 2 | Status: COMPLETED